These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28146132)

  • 1. A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost.
    Krupa M; Chodyński M; Ostaszewska A; Cmoch P; Dams I
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28146132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel convergent synthesis of the antiglaucoma PGF2α analogue bimatoprost.
    Dams I; Chodyński M; Krupa M; Pietraszek A; Zezula M; Cmoch P; Kosińska M; Kutner A
    Chirality; 2013 Mar; 25(3):170-9. PubMed ID: 23381781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic uses of prostaglandin F(2α) analogues in ocular disease and novel synthetic strategies.
    Dams I; Wasyluk J; Prost M; Kutner A
    Prostaglandins Other Lipid Mediat; 2013; 104-105():109-21. PubMed ID: 23353557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.
    Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
    Curr Eye Res; 2008 Apr; 33(4):303-12. PubMed ID: 18398704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostaglandin F(2α) analogues on endothelin-1-induced impairment of rabbit ocular blood flow: comparison among tafluprost, travoprost, and latanoprost.
    Kurashima H; Watabe H; Sato N; Abe S; Ishida N; Yoshitomi T
    Exp Eye Res; 2010 Dec; 91(6):853-9. PubMed ID: 20868682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tafluprost: the first preservative-free prostaglandin to treat open-angle glaucoma and ocular hypertension.
    Swymer C; Neville MW
    Ann Pharmacother; 2012 Nov; 46(11):1506-10. PubMed ID: 23092867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin analog treatment of glaucoma and ocular hypertension.
    Alexander CL; Miller SJ; Abel SR
    Ann Pharmacother; 2002 Mar; 36(3):504-11. PubMed ID: 11895065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film.
    Sedlak L; Zych M; Wojnar W; Wyględowska-Promieńska D
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31336766
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 - 2018).
    Angeli A; Supuran CT
    Expert Opin Ther Pat; 2019 Oct; 29(10):793-803. PubMed ID: 31462124
    [No Abstract]   [Full Text] [Related]  

  • 12. Benefits of Tafluprost and Timolol Fixed-Dose Combination for the Treatment of Glaucoma Are Confirmed by Studies on Experimental Animal Models.
    Akaishi T; Shimazaki A; Tonouchi A; Ueda K; Miyawaki N; Kawazu K
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):518-24. PubMed ID: 26325164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension.
    Erb C; Lanzl I; Seidova SF; Kimmich F
    Adv Ther; 2011 Jul; 28(7):575-85. PubMed ID: 21725844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma.
    Klimko PG; Sharif NA
    Br J Pharmacol; 2019 Apr; 176(8):1051-1058. PubMed ID: 29665040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.
    Fuwa M; Ueda K; Akaishi T; Yamashita N; Kirihara T; Shimazaki A; Mano H; Kawazu K
    PLoS One; 2016; 11(7):e0158797. PubMed ID: 27383260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tafluprost: a novel prostaglandin analog for treatment of glaucoma.
    Pantcheva MB; Seibold LK; Awadallah NS; Kahook MY
    Adv Ther; 2011 Sep; 28(9):707-15. PubMed ID: 21858491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tafluprost--a novel prostaglandin F2alpha analogue].
    Petrov SIu
    Vestn Oftalmol; 2014; 130(5):85-95. PubMed ID: 25711069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.
    Yamada H; Yoneda M; Gosho M; Kato T; Zako M
    BMC Ophthalmol; 2016 Mar; 16():26. PubMed ID: 26956170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension.
    Konstas AG; Quaranta L; Katsanos A; Riva I; Tsai JC; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Floriani I; Haidich AB
    Br J Ophthalmol; 2013 Dec; 97(12):1510-5. PubMed ID: 23681371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprost.
    Traverso CE; Ropo A; Papadia M; Uusitalo H
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):97-104. PubMed ID: 20148656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.